 |
|
Mapping Retinal Fluorescein Leakage With Confocal Scanning Laser Fluorometry of the Human Vitreous
Conceição L. Lobo, MD, MSc;
Rui C. Bernardes, BSc;
Fernando J. Santos, BSc;
José G. Cunha-Vaz, MD, PhD
Arch Ophthalmol. 1999;117:631-637.
Objective To demonstrate an objective, quantitative, and sensitive method of mapping retinal fluorescein leakage into the vitreous while simultaneously imaging the retina.
Methods A prototype Zeiss confocal scanning laser ophthalmoscope was modified to obtain fluorometric measurements from 18 optical planes across the retina and cortical vitreous, separated from each other by 150 µm, and parallel to the retinal surface. After intravenous administration of fluorescein, an axial graphic of equivalent fluorescein concentration in the vitreous may be obtained from any region of interest. After correcting for fluorescence levels in the retina and choroid and plasma levels of free fluorescein, permeability values of the blood-retinal barrier to fluorescein were obtained from 1512 regions measuring 75 x 75 µm, from a total 3150 x 2700-µm area of the fundus, generating a detailed map of retinal fluorescein leakage. The method was assessed in vitro and in 7 healthy subjects who underwent scans during separate visits. Depth resolution and influence of chorioretinal fluorescence were further tested in 2 patients with multiple drusen and in 2 eyes after vitrectomy. Fourteen eyes from 7 patients with diabetes and nonproliferative retinopathy were also examined. Lateral resolution was tested in 3 diabetic eyes that underwent focal photocoagulation. Four eyes from 2 patients with diabetes and minimal retinopathy were examined at 3-month intervals. All eyes examined had less than 2 diopters of astigmatism.
Results Characteristics of the modified confocal scanning laser fluorometer included a lower limit of detection equal to 0.40 Eq ng/mL and depth precision of ±15 µm. Values for the blood-retinal barrier permeability index in healthy subjects, measured 30 minutes after a single intravenous pulse of fluorescein (14 mg/kg), ranged from 1.3 ± 0.4 x 10-6 cm/s over the foveal avascular zone to 2.2 ± 0.6 x 10-6 cm/s over vessels in the retina. Diabetic eyes with retinopathy showed higher values, ranging from 1.4 to 15.0 x 10-6 cm/s. Vitrectomized eyes and eyes with multiple drusen showed the validity of the correction algorithm demonstrating that measurements of fluorescence in the vitreous are not influenced by the chorioretinal fluorescence level. Argon laser photocoagulation burns placed in the diabetic retina demonstrated a lateral resolution on the order of 75 to 100 µm. Intravisit and intervisit reproducibility was ±10.2% and ±13%, respectively.
Conclusions This new method measures localized alterations of the blood-retinal barrier and allows for direct correlation with retinal anatomy. Its most interesting feature is the ability to map retinal fluorescein leakage while simultaneously imaging the retina. This capability is expected to improve our understanding and management of retinal disease.
From the Center of Ophthalmology, University Hospital and Institute for Biomedical Research in Light and Image, Coimbra, Portugal.
RELATED ARTICLE
Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 1999;117(5):707-708.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Three-Year Follow-up Study of Blood-Retinal Barrier and Retinal Thickness Alterations in Patients With Type 2 Diabetes Mellitus and Mild Nonproliferative Diabetic Retinopathy
Lobo et al.
Arch Ophthalmol 2004;122:211-217.
ABSTRACT
| FULL TEXT
One-Year Follow-up of Blood-Retinal Barrier and Retinal Thickness Alterations in Patients With Type 2 Diabetes Mellitus and Mild Nonproliferative Retinopathy
Lobo et al.
Arch Ophthalmol 2001;119:1469-1474.
ABSTRACT
| FULL TEXT
Alterations of the Blood-Retinal Barrier and Retinal Thickness in Preclinical Retinopathy in Subjects With Type 2 Diabetes
Lobo et al.
Arch Ophthalmol 2000;118:1364-1369.
ABSTRACT
| FULL TEXT
|
